Senna Solution
NDC 0536-1483
Product Information
Senna is a OTC MONOGRAPH DRUG-approved product labeled by Rugby Laboratories. Sennosides are used to treat constipation. It is supplied as a solution for oral administration. This product entry covers the primary NDC 0536-1483 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 0536-1483?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SENNOSIDES A AND B (UNII: 1B5FPI42EN)
- SENNOSIDES A AND B (UNII: 1B5FPI42EN) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- WATER (UNII: 059QF0KO0R)
- SUCROSE (UNII: C151H8M554)
* Please review the full disclaimer at the bottom of this page.
Patient Education
Senna
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
[Learn More]
* Please review the full disclaimer at the bottom of this page.